Malcolm C. Kendall

DNA Direct, Inc. operates as a holding company with interests in providing genetic information and testing services. Its products include genomic medicine network, decision support program, coverage management. The company was founded by Ryan Phelan and Deena Aljuhani Abdulaziz in 2005 and it is headquartered in Bluffton, SC.

Rady Children's Hospital and Health Center of San Diego provides healthcare services. The firm offers nephrology, cardiology, dermatology, hematology, urology, radiology, and oncology services. The company was founded in 1954 and is headquartered in San Diego, CA.

LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada.

Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Allergen NCE, Inc.is a national research network, seeking asthma and allergy treatment from a naturopath. It invests in training the next generation of researchers, innovators and clinician-scientists. The company was founded in 2004 and is headquartered in Hamilton, Canada.

The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country.

Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada.

Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada.

Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada.

Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA.

Transferra Nanosciences, Inc. manufactures and distributes of pharmaceutical products. It is a contract development and manufacturing organization that provides products and services to biotechnology companies engaged in the development of pharmaceutical products. Its products include LIPEX Extruder and Video Gallery. The company was founded in 1991 and is headquartered in Burnaby, Canada.

Mesentech, Inc. engages in the development of drug conjugate that delivers medicines selectively to the bone. Its bone anabolic drug conjugates are used as a treatment for renal osteodystrophy, osteogenesis imperfecta, and Duchenne associated osteoporosis. The company was founded by Robert Young, Ian McBeath, Michael Underhill, Pieter R. Cullis, and Fabio Rossi and is headquartered in Vancouver, Canada.

adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada.

Abozymes Biomedical, Inc. develops biotechnology for blood transfusions and organ transplant services. The CEO of the Canadian company is John Coleman.